Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1185

1.

JNK-mediated phosphorylation of SARM1 regulates NAD+ cleavage activity to inhibit mitochondrial respiration.

Murata H, Khine CC, Nishikawa A, Yamamoto KI, Kinoshita R, Sakaguchi M.

J Biol Chem. 2018 Oct 17. pii: jbc.RA118.004578. doi: 10.1074/jbc.RA118.004578. [Epub ahead of print]

PMID:
30333228
2.

Using Deep Learning and transform learning to accurately diagnose early-onset glaucoma from macular optical coherence tomography images.

Asaoka R, Murata H, Hirasawa K, Fujino Y, Matsuura M, Miki A, Kanamoto T, Ikeda Y, Mori K, Iwase A, Shoji N, Inoue K, Yamagami J, Araie M.

Am J Ophthalmol. 2018 Oct 11. pii: S0002-9394(18)30589-0. doi: 10.1016/j.ajo.2018.10.007. [Epub ahead of print]

PMID:
30316669
3.

A multimodal molecular imaging study evaluates pharmacological alteration of the tumor microenvironment to improve radiation response.

Takakusagi Y, Naz S, Takakusagi K, Ishima M, Murata H, Ohta K, Miura M, Sugawara F, Sakaguchi K, Kishimoto S, Munasinghe JP, Mitchell JB, Krishna MC.

Cancer Res. 2018 Oct 9. pii: canres.1654.2018. doi: 10.1158/0008-5472.CAN-18-1654. [Epub ahead of print]

PMID:
30301838
4.

Development of a deep residual learning algorithm to screen for glaucoma from fundus photography.

Shibata N, Tanito M, Mitsuhashi K, Fujino Y, Matsuura M, Murata H, Asaoka R.

Sci Rep. 2018 Oct 2;8(1):14665. doi: 10.1038/s41598-018-33013-w.

5.

SUVmax-based Parameters of FDG-PET/CT Reliably Predict Pathologic Complete Response After Preoperative Hyperthermo-chemoradiotherapy in Rectal Cancer.

Murata H, Okamoto M, Takahashi T, Motegi M, Ogoshi K, Shoji H, Onishi M, Takakusagi Y, Okonogi N, Kawamura H, Okazaki A, Asao T, Kuwano H, Nakano T.

Anticancer Res. 2018 Oct;38(10):5909-5916. doi: 10.21873/anticanres.12935.

PMID:
30275218
6.

Correlation between elastic energy stored in an eye and visual field progression in glaucoma.

Aoki S, Murata H, Nakakura S, Nakao Y, Matsuura M, Kiuchi Y, Asaoka R.

PLoS One. 2018 Sep 21;13(9):e0204451. doi: 10.1371/journal.pone.0204451. eCollection 2018.

7.

A Liquid-core Liquid-cladding Optical Waveguide Based on Thermal Gradients across Laminar Flow of Water in Capillary Tubing.

Nakamura M, Murata H, Sato K, Tsunoda KI.

Anal Sci. 2018 Sep 14. doi: 10.2116/analsci.18N015. [Epub ahead of print] No abstract available.

8.

Delayed C5 Palsy After Anterior Cervical Decompression Surgery: Preoperative Foraminal Stenosis and Postoperative Spinal Cord Shift Increase the Risk of Palsy.

Takase H, Murata H, Sato M, Tanaka T, Miyazaki R, Yoshizumi T, Tateishi K, Kawahara N, Yamamoto T.

World Neurosurg. 2018 Sep 12. pii: S1878-8750(18)32049-7. doi: 10.1016/j.wneu.2018.08.240. [Epub ahead of print]

PMID:
30218802
9.

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients.

Azuma K, Asaoka R, Matsuda A, Lee J, Shimizu K, Inui H, Murata H, Ogawa A, Yamamoto M, Inoue T, Obata R.

Clin Ophthalmol. 2018 Aug 29;12:1589-1597. doi: 10.2147/OPTH.S172115. eCollection 2018.

10.

Characteristics and risk factors of recurrent keratoconus over the long term after penetrating keratoplasty.

Yoshida J, Murata H, Miyai T, Shirakawa R, Toyono T, Yamagami S, Usui T.

Graefes Arch Clin Exp Ophthalmol. 2018 Sep 8. doi: 10.1007/s00417-018-4131-5. [Epub ahead of print]

PMID:
30196480
11.

Tailoring Site Specificity of Bioconjugation Using Step-Wise Atom-Transfer Radical Polymerization on Proteins.

Carmali S, Murata H, Matyjaszewski K, Russell AJ.

Biomacromolecules. 2018 Oct 8;19(10):4044-4051. doi: 10.1021/acs.biomac.8b01064. Epub 2018 Sep 20.

PMID:
30189145
12.

Multicenter, Open-Label, Randomized Controlled Trial of Warfarin and Edoxaban Tosilate Hydrate for the Treatment of Deep Vein Thrombosis in Persons with Severe Motor Intellectual Disabilities.

Ohmori H, Nakamura M, Kada A, Saito AM, Sanayama Y, Shinagawa T, Fujita H, Wakisaka A, Maruhashi K, Okumura A, Takizawa N, Murata H, Inoue M, Kaneko H, Taniguchi H, Kawasaki M, Sano N, Akaboshi S, Tanuma N, Sone S, Kumode M, Takechi T, Koretsune Y, Sumimoto R, Miyanomae T.

Kurume Med J. 2018 Aug 30. doi: 10.2739/kurumemedj.MS651003. [Epub ahead of print]

13.

Intraventricular Rituximab in Pediatric CD20-positive Refractory Primary Central Nervous System Lymphoma.

Wada-Shimosato Y, Ikeda J, Tsujimoto SI, Sasaki K, Yanagimachi M, Kajiwara R, Shiba N, Murata H, Kawahara N, Yamanaka S, Tanoshima R, Ito S.

J Pediatr Hematol Oncol. 2018 Aug 17. doi: 10.1097/MPH.0000000000001291. [Epub ahead of print]

PMID:
30124546
14.

Intestinal fatty acid-binding protein levels in patients with chronic renal failure.

Okada K, Sekino M, Funaoka H, Sato S, Ichinomiya T, Murata H, Maekawa T, Nishikido M, Eishi K, Hara T.

J Surg Res. 2018 Oct;230:94-100. doi: 10.1016/j.jss.2018.04.057. Epub 2018 May 25.

PMID:
30100046
15.

Intramolecular Interactions of Conjugated Polymers Mimic Molecular Chaperones to Stabilize Protein-Polymer Conjugates.

Baker SL, Munasinghe A, Murata H, Lin P, Matyjaszewski K, Colina CM, Russell AJ.

Biomacromolecules. 2018 Sep 10;19(9):3798-3813. doi: 10.1021/acs.biomac.8b00927. Epub 2018 Aug 22.

PMID:
30086223
16.

Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.

Cui X, Cao Z, Wang S, Lee RB, Wang X, Murata H, Adler SP, McVoy MA, Snapper CM.

Vaccine. 2018 Sep 5;36(37):5580-5590. doi: 10.1016/j.vaccine.2018.07.056. Epub 2018 Aug 3.

PMID:
30082162
17.

Changes in corneal biomechanics and intraocular pressure following cataract surgery.

Hirasawa K, Nakakura S, Nakao Y, Fujino Y, Matsuura M, Murata H, Kiuchi Y, Asaoka R.

Am J Ophthalmol. 2018 Jul 30. pii: S0002-9394(18)30406-9. doi: 10.1016/j.ajo.2018.07.025. [Epub ahead of print]

PMID:
30071213
18.

[Efficacy and Safety of Salvage ESHAP Chemotherapy for Recurrent/Refractory PCNSLs].

Nagao K, Nakamura T, Tateishi K, Sato H, Shimizu N, Suenaga J, Murata H, Kanno H, Yamamoto T.

No Shinkei Geka. 2018 Jul;46(7):575-581. doi: 10.11477/mf.1436203773. Japanese.

PMID:
30049898
19.

Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms.

Ruma IMW, Kinoshita R, Tomonobu N, Inoue Y, Kondo E, Yamauchi A, Sato H, Sumardika IW, Chen Y, Yamamoto KI, Murata H, Toyooka S, Nishibori M, Sakaguchi M.

Cancers (Basel). 2018 Jul 23;10(7). pii: E239. doi: 10.3390/cancers10070239.

20.

Decidualization of the human endometrium.

Okada H, Tsuzuki T, Murata H.

Reprod Med Biol. 2018 Feb 1;17(3):220-227. doi: 10.1002/rmb2.12088. eCollection 2018 Jul. Review.

21.

Improving the structure-function relationship in glaucomatous and normative eyes by incorporating photoreceptor layer thickness.

Matsuura M, Fujino Y, Kanamoto T, Murata H, Yanagisawa M, Hirasawa K, Inoue T, Shoji N, Inoue K, Yamagami J, Asaoka R.

Sci Rep. 2018 Jul 11;8(1):10450. doi: 10.1038/s41598-018-28821-z.

22.

The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone/progesterone receptor pathway.

Yasuda K, Sumi GI, Murata H, Kida N, Kido T, Okada H.

Life Sci. 2018 Aug 15;207:508-515. doi: 10.1016/j.lfs.2018.07.004. Epub 2018 Jul 4.

PMID:
29981319
23.

Anesthetic management of patients with systemic mastocytosis.

Ishii K, Miyoshi H, Akiyama D, Makita T, Sumikawa K, Murata H, Hara T.

J Clin Anesth. 2018 Nov;50:61. doi: 10.1016/j.jclinane.2018.06.047. Epub 2018 Jul 2. No abstract available.

PMID:
29980002
24.

Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis.

Hosaka S, Katagiri H, Niwakawa M, Harada H, Wasa J, Murata H, Takahashi M.

Int J Clin Oncol. 2018 Jun 29. doi: 10.1007/s10147-018-1310-7. [Epub ahead of print]

PMID:
29959563
25.

Three-dimensional multimodality fusion imaging as an educational and planning tool for deep-seated meningiomas.

Sato M, Tateishi K, Murata H, Kin T, Suenaga J, Takase H, Yoneyama T, Nishii T, Tateishi U, Yamamoto T, Saito N, Inoue T, Kawahara N.

Br J Neurosurg. 2018 Jun 26:1-7. doi: 10.1080/02688697.2018.1485877. [Epub ahead of print]

PMID:
29943649
26.

Clinical Advantage of Chest-wall Post-mastectomy Radiation Therapy Without Bolus.

Shiba S, Okamoto M, Kiyohara H, Okano N, Yoshimoto Y, Murata H, Irie D, Katoh H, Nakano T.

In Vivo. 2018 Jul-Aug;32(4):961-965. doi: 10.21873/invivo.11335.

27.

Detection of Longitudinal Visual Field Progression in Glaucoma Using Machine Learning.

Yousefi S, Kiwaki T, Zheng Y, Sugiura H, Asaoka R, Murata H, Lemij H, Yamanishi K.

Am J Ophthalmol. 2018 Sep;193:71-79. doi: 10.1016/j.ajo.2018.06.007. Epub 2018 Jun 18.

PMID:
29920226
28.

Long-term clinical outcome in patients with high-grade soft tissue sarcoma who were treated with surgical adjuvant therapy using acridine orange after intra-lesional or marginal resection.

Nakamura T, Kusuzaki K, Matsubara T, Murata H, Hagi T, Asanuma K, Sudo A.

Photodiagnosis Photodyn Ther. 2018 Sep;23:165-170. doi: 10.1016/j.pdpdt.2018.06.001. Epub 2018 Jun 7.

PMID:
29885811
29.

Time-dependent changes of the intention of mothers in Japan to inoculate their daughters with the HPV vaccine after suspension of governmental recommendation.

Yagi A, Ueda Y, Tanaka Y, Nakae R, Kakubari R, Morimoto A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Matsumura N, Yoshino K, Kimura T, Saito J, Ikeda S, Asai-Sato M, Miyagi E, Sekine M, Enomoto T, Hirai K, Horikoshi Y, Takagi T, Shimura K.

Hum Vaccin Immunother. 2018 Jun 8:1-6. doi: 10.1080/21645515.2018.1480240. [Epub ahead of print]

PMID:
29883254
30.

Mapping the Central 10° Visual Field to the Optic Nerve Head Using the Structure-Function Relationship.

Fujino Y, Murata H, Matsuura M, Yanagisawa M, Shoji N, Inoue K, Yamagami J, Asaoka R.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2801-2807. doi: 10.1167/iovs.17-23485.

PMID:
29860465
31.

Corneal biomechanical properties are associated with the activity and prognosis of Angioid Streaks.

Asano S, Nakajima K, Kure K, Azuma K, Shimizu K, Murata H, Inoue T, Obata R, Asaoka R.

Sci Rep. 2018 May 25;8(1):8130. doi: 10.1038/s41598-018-26430-4.

32.

Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy.

Asano S, Azuma K, Shimizu K, Yamamoto R, Lee J, Murata H, Inoue T, Asaoka R, Obata R.

PLoS One. 2018 May 10;13(5):e0197042. doi: 10.1371/journal.pone.0197042. eCollection 2018.

33.

Development of antibacterial denture cleaner for brushing containing tea tree and lemongrass essential oils.

Koseki Y, Tanaka R, Murata H.

Dent Mater J. 2018 Jul 29;37(4):659-666. doi: 10.4012/dmj.2017-295. Epub 2018 May 2.

34.

Tiny Falx Meningioma Causing Massive Interhemispheric Subdural Hematoma: A Case Report.

Suzuki Y, Fujimoto M, Kawakita F, Asakura F, Murata H, Morooka Y, Suzuki H.

NMC Case Rep J. 2018 Mar 9;5(2):51-55. doi: 10.2176/nmccrj.cr.2017-0091. eCollection 2018 Apr.

35.

Validating Variational Bayes Linear Regression Method With Multi-Central Datasets.

Murata H, Zangwill LM, Fujino Y, Matsuura M, Miki A, Hirasawa K, Tanito M, Mizoue S, Mori K, Suzuki K, Yamashita T, Kashiwagi K, Shoji N, Asaoka R.

Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1897-1904. doi: 10.1167/iovs.17-22907.

36.

Reply.

Matsuura M, Murata H, Fujino Y, Hirasawa K, Yanagisawa M, Asaoka R.

Am J Ophthalmol. 2018 Jun;190:201-202. doi: 10.1016/j.ajo.2018.03.022. Epub 2018 Apr 5. No abstract available.

PMID:
29627064
37.

Asymmetric Patterns of Visual Field Defect in Primary Open-Angle and Primary Angle-Closure Glaucoma.

Yousefi S, Sakai H, Murata H, Fujino Y, Garway-Heath D, Weinreb R, Asaoka R.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1279-1287. doi: 10.1167/iovs.17-22980.

PMID:
29625450
38.

Studies on the Unusual 1β-Hydroxylated Bile Acid Biosynthesis in Infants.

Nomura Y, Murata H, Sasai H, Kimura A, Kurosawa T, Sasaki T, Murai T.

Biol Pharm Bull. 2018;41(4):597-603. doi: 10.1248/bpb.b17-00986.

39.

Radiation recall pneumonitis induced by ifosfamide for malignant soft tissue tumor arising from the chest wall: A case report.

Murata H, Koyama K, Takezawa Y, Nishigaki Y.

Mol Clin Oncol. 2018 Apr;8(4):595-599. doi: 10.3892/mco.2018.1562. Epub 2018 Jan 31.

40.

Distribution and metabolism of 14C-Sulfoquinovosylacylpropanediol (14C-SQAP) after a single intravenous administration in tumor-bearing mice.

Ruike T, Kanai Y, Iwabata K, Matsumoto Y, Murata H, Ishima M, Ohta K, Oshige M, Katsura S, Kuramochi K, Kamisuki S, Sahara H, Miura M, Sugawara F, Sakaguchi K.

Xenobiotica. 2018 Mar 15:1-45. doi: 10.1080/00498254.2018.1448949. [Epub ahead of print]

PMID:
29543539
41.

Tumor necrosis factor-α downregulates the REIC/Dkk-3 tumor suppressor gene in normal human skin keratinocytes.

Kataoka K, Maehara N, Ayabe Y, Murata H, Huh NH, Sakaguchi M.

Mol Med Rep. 2018 May;17(5):6661-6666. doi: 10.3892/mmr.2018.8676. Epub 2018 Mar 5.

PMID:
29512745
42.

Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [18F]-Fluoro-2-Deoxy-d-Glucose: A Case Report.

Ohtake M, Tateishi K, Murata H, Nagashima Y, Yamanaka S, Yamamoto T.

World Neurosurg. 2018 Jun;114:47-52. doi: 10.1016/j.wneu.2018.02.147. Epub 2018 Mar 3.

PMID:
29510284
43.

Solid-phase synthesis of protein-polymers on reversible immobilization supports.

Murata H, Carmali S, Baker SL, Matyjaszewski K, Russell AJ.

Nat Commun. 2018 Feb 27;9(1):845. doi: 10.1038/s41467-018-03153-8.

44.

The effect of air pulse-driven whole eye motion on the association between corneal hysteresis and glaucomatous visual field progression.

Aoki S, Murata H, Matsuura M, Fujino Y, Nakakura S, Nakao Y, Kiuchi Y, Asaoka R.

Sci Rep. 2018 Feb 14;8(1):2969. doi: 10.1038/s41598-018-21424-8.

45.

Factors associated with developing a fear of falling in subjects with primary open-angle glaucoma.

Adachi S, Yuki K, Awano-Tanabe S, Ono T, Shiba D, Murata H, Asaoka R, Tsubota K.

BMC Ophthalmol. 2018 Feb 13;18(1):39. doi: 10.1186/s12886-018-0706-5.

46.

Validity of combination use of activity record and accelerometry to measure free-living total energy expenditure in female endurance runners.

Yoshida A, Ishikawa-Takata K, Tanaka S, Suzuki N, Nakae S, Murata H, Taguchi M, Higuchi M.

J Strength Cond Res. 2018 Jan 30. doi: 10.1519/JSC.0000000000002205. [Epub ahead of print]

PMID:
29389693
47.

Changes in Axial Length and Progression of Visual Field Damage in Glaucoma.

Yanagisawa M, Yamashita T, Matsuura M, Fujino Y, Murata H, Asaoka R.

Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):407-417. doi: 10.1167/iovs.17-22949.

PMID:
29351357
48.

Detecting glaucomatous progression with infrequent visual field testing.

Anderson AJ, Asokan R, Murata H, Asaoka R.

Ophthalmic Physiol Opt. 2018 Mar;38(2):174-182. doi: 10.1111/opo.12439. Epub 2018 Jan 8.

PMID:
29315705
49.

Bow Hunter's Syndrome by Nondominant Vertebral Artery Compression: A Case Report, Literature Review, and Significance of Downbeat Nystagmus as the Diagnostic Clue.

Iida Y, Murata H, Johkura K, Higashida T, Tanaka T, Tateishi K.

World Neurosurg. 2018 Mar;111:367-372. doi: 10.1016/j.wneu.2017.12.167. Epub 2018 Jan 5. Review.

PMID:
29309982
50.

Signal Diversity of Receptor for Advanced Glycation End Products.

Sakaguchi M, Kinoshita R, Putranto EW, Ruma IMW, Sumardika IW, Youyi C, Tomonobu N, Yamamoto KI, Murata H.

Acta Med Okayama. 2017 Dec;71(6):459-465. doi: 10.18926/AMO/55582. Review.

Supplemental Content

Loading ...
Support Center